EMVision Medical Devices Secures Ethics Approval for Pivotal US Brain Scanner Trial

MT Newswires Live

2025/02/12

EMVision Medical Devices (ASX:EMV) has secured central Institutional Review Board ethics approval for its multi-center trial of the EMVision emu brain scanner in the US, according to a Wednesday filing with the Australian bourse.

The trial, designated non-significant risk (NSR), allows for a faster start-up and enrollment process, the filing said.

Site contracts are being finalized, with US investigational sites to be named soon, the filing added.

Australian ethics approval is pending while the trial is on track for March activation to support the US Food and Drug Administration's De Novo clearance, per the filing.

Price (AUD): $1.86, Change: $-0.010, Percent Change: -0.53%

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2510611533"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2510611533\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2510611533?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-12 07:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510611533","market":"fut","top_or_hot":-1,"title":"EMVision Medical Devices Secures Ethics Approval for Pivotal US Brain Scanner Trial","media":"MT Newswires Live","content":"<html><body><p> EMVision Medical Devices (ASX:EMV) has secured central Institutional Review Board ethics approval for its multi-center trial of the EMVision emu brain scanner in the US, according to a Wednesday filing with the Australian bourse.</p><p>The trial, designated non-significant risk (NSR), allows for a faster start-up and enrollment process, the filing said.</p><p>Site contracts are being finalized, with US investigational sites to be named soon, the filing added.</p><p>Australian ethics approval is pending while the trial is on track for March activation to support the US Food and Drug Administration's De Novo clearance, per the filing.</p><p>Price (AUD): $1.86, Change: $-0.010, Percent Change: -0.53%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EMVision Medical Devices Secures Ethics Approval for Pivotal US Brain Scanner Trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEMVision Medical Devices Secures Ethics Approval for Pivotal US Brain Scanner Trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-12 07:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> EMVision Medical Devices (ASX:EMV) has secured central Institutional Review Board ethics approval for its multi-center trial of the EMVision emu brain scanner in the US, according to a Wednesday filing with the Australian bourse.</p><p>The trial, designated non-significant risk (NSR), allows for a faster start-up and enrollment process, the filing said.</p><p>Site contracts are being finalized, with US investigational sites to be named soon, the filing added.</p><p>Australian ethics approval is pending while the trial is on track for March activation to support the US Food and Drug Administration's De Novo clearance, per the filing.</p><p>Price (AUD): $1.86, Change: $-0.010, Percent Change: -0.53%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4125","symbol_name":"广播","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2510611533","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510611533","pubTimestamp":1739316507,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EMVision Medical Devices  has secured central Institutional Review Board ethics approval for its multi-center trial of the EMVision emu brain scanner in the US, according to a Wednesday filing with the Australian bourse.The trial, designated non-significant risk , allows for a faster start-up and enrollment process, the filing said.Site contracts are being finalized, with US investigational sites to be named soon, the filing added.Australian ethics approval is pending while the trial is on track for March activation to support the US Food and Drug Administration's De Novo clearance, per the filing.Price : $1.86, Change: $-0.010, Percent Change: -0.53%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4125":"广播","LU2238339852.HKD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (HKD) ACC","EMV.AU":"EMVISION MEDICAL DEVICES LTD","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","NSR":"Nomad Royalty Ltd.","BK7010":"特种房地产投资信托","BK7007":"医疗保健设备","LU0426412945.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) ACC","NSR.AU":"NATIONAL STORAGE REIT","BK7151":"自存仓储房地产信托","LU0426417589.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC","LU1043141123.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2","LU0994945656.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC 2"},"translate_title":"EMVision Medical Devices获得美国关键脑部扫描仪试验的伦理批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NSR":1,"NSR.AU":1,"AUD":1,"EMV.AU":0.9},"content_text":"EMVision Medical Devices (ASX:EMV) has secured central Institutional Review Board ethics approval for its multi-center trial of the EMVision emu brain scanner in the US, according to a Wednesday filing with the Australian bourse.The trial, designated non-significant risk (NSR), allows for a faster start-up and enrollment process, the filing said.Site contracts are being finalized, with US investigational sites to be named soon, the filing added.Australian ethics approval is pending while the trial is on track for March activation to support the US Food and Drug Administration's De Novo clearance, per the filing.Price (AUD): $1.86, Change: $-0.010, Percent Change: -0.53%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}